Inventor · disambiguated record
Pierre Bruhns
Also filed as: BRUHNS PIERRE
1 granted patent·7 pending applications·0 citations·filing 2009–2024
13Inventor score
Top patents by PatentIndex Score
8 records- 0162US2025025541A1Immunogenic product comprising il-4 and/or il-13 for treating disorders associated with aberrant il-4 and/or il 13 expression or activityNEOVACS·Filed 2024·Application pending·0 cites
- 0255US12059457B2Immunogenic product comprising IL-4 and/or IL-13 for treating disorders associated with aberrant IL-4 and/or IL 13 expression or activityNEOVACS·Filed 2019·Granted Aug 13, 2024·0 cites·8 claims
- 0355US2024076410A1Fc-engineered anti-human ige antibodies and methods of useINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0443US2023364232A1IMMUNOGENIC PRODUCT COMPRISING AN IgE FRAGMENT FOR TREATING IgE-MEDIATED INFLAMMATORY DISORDERSNEOVACS·Filed 2021·Application pending·0 cites
- 0542US2010028263A1Methods for inhibiting mast cell activation and treating mast cell-dependent inflammatory diseases and disorders using lactobacillusPASTEUR INSTITUT·Filed 2009·Application pending·0 cites
- 0638US2023227559A1New antibody blocking human fcgriiia and fcgriiibPASTEUR INSTITUT·Filed 2020·Application pending·0 cites
- 0735US2021115156A1Fc-engineered anti-human ige antibodies and methods of useINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0832US2015322152A1Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shockPASTEUR INSTITUT·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →